miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia
. Inhibition of miR-30b-5p expression and supplementation with ferroptosis inhibitors attenuated the PE symptoms in rat models, making miR-30b-5p a potential therapeutic target for PE.
